# K150061: Lucent; Lucent Ti-Bond Systems

- Pathway: 510(k) (Traditional)
- Applicant: Spinal Elements, Inc.
- Decided: May 19, 2015 after 126 days
- Product code: MAX (Intervertebral Fusion Device With Bone Graft, Lumbar)
- Device class: 2
- Regulation: 21 CFR 888.3080
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 4 generations back to P980048 (2001). 8 ancestors in all.
135 later devices descend from it; 10 cite it directly.
0 of 144 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K071724: Lucent, Spinal Elements, Inc. (2007) Summary page 4.
- K110632: Lucent or Lucent Magnum, Spinal Elements, Inc. (2012) Summary page 4.
- K122967: Lucent, Spinal Elements, Inc. (2013) Summary page 5.

## Most influential descendants
- K170235: Lucent® (2017), 107 descendants of its own
- K152011: Lucent Intervertebral Body Fusion Device (2016), 106 descendants of its own
- K181837: Spinal Elements Ti-Bond coated devices (2018), 98 descendants of its own
- K190546: NEXXT MATRIXX Stand Alone Cervical System (2019), 93 descendants of its own
- K200543: NEXXT MATRIXX Stand Alone Cervical-Turn Lock (-TL) System (2020), 72 descendants of its own

## Indications for use
Lucent® and Lucent Ti-Bond® are intervertebral body fusion devices intended for spinal fusion procedures at one or two contiguous levels (L2-S1) in skeletally mature patients with degenerative disc disease (DDD). DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. DDD patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved levels. These patients may have had a previous non-fusion spinal surgery at the involved spinal level(s). These devices are intended to be used with supplemental spinal fixation systems that have been cleared for use in the lumbosacral spine (i.e., posterior pedicle screw and rod systems, anterior plate systems, and anterior screw and rod systems). These devices are intended to be used with autogenous bone graft. Patients must have undergone a regimen of at least six (6) months non-operative treatment prior to being treated with these devices.

Source page: https://510kreport.com/device/K150061
Methodology: https://510kreport.com/methodology